353 related articles for article (PubMed ID: 33975832)
1. Severe cutaneous presentation of hydralazine-induced ANCA vasculitis without renal or pulmonary involvement, complicated by DIC.
Huo MX; Avelino ARM; Singh G
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975832
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
[TBL] [Abstract][Full Text] [Related]
3. Overlapping drug-induced vasculitis, ANCA-associated vasculitis, and lupus nephritis caused by low-dose hydralazine.
Bhatnagar M; Agaronov A; Sarkisyan E; Sotoudeh Deilamy I; Pepito D; Akhondi H
Int J Rheum Dis; 2023 Nov; 26(11):2272-2277. PubMed ID: 37452463
[TBL] [Abstract][Full Text] [Related]
4. Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.
Doughem K; Battisha A; Sheikh O; Konduru L; Madoukh B; Al-Sadawi M; Shaikh S
Curr Cardiol Rev; 2021; 17(2):182-187. PubMed ID: 32418528
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Al-Abdouh A; Siyal AM; Seid H; Bekele A; Garcia P
J Med Case Rep; 2020 Apr; 14(1):47. PubMed ID: 32290867
[TBL] [Abstract][Full Text] [Related]
6. Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis.
Zuckerman R; Patel M; Costanzo EJ; Dounis H; Haj RA; Seyedali S; Asif A
J Bras Nefrol; 2018; 40(2):193-197. PubMed ID: 29738027
[TBL] [Abstract][Full Text] [Related]
7. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
[TBL] [Abstract][Full Text] [Related]
8. Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome.
Aeddula NR; Pathireddy S; Ansari A; Juran PJ
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413463
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
[TBL] [Abstract][Full Text] [Related]
10. Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Paley MA; Edrees F; Kudose S; Gaut JP; Ranganathan P; Vijayan A
Saudi J Kidney Dis Transpl; 2019; 30(1):226-230. PubMed ID: 30804286
[TBL] [Abstract][Full Text] [Related]
11. Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.
Russe-Russe JR; Pellegrini JR; Alvarez-Betancourt A; Munshi RF; Anand P
Cureus; 2021 Oct; 13(10):e18974. PubMed ID: 34820229
[TBL] [Abstract][Full Text] [Related]
12. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Marina VP; Malhotra D; Kaw D
Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
[TBL] [Abstract][Full Text] [Related]
13. Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody Vasculitis Presenting with Red Eye Followed by Pulmonary Hemorrhage: Diagnostic and Management Considerations.
Alidoost M; Cheng J; Alpert DR
Am J Case Rep; 2020 Dec; 21():e925200. PubMed ID: 33293503
[TBL] [Abstract][Full Text] [Related]
14. Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis.
Yokogawa N; Vivino FB
Mod Rheumatol; 2009; 19(3):338-47. PubMed ID: 19424772
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
Kumar B; Strouse J; Swee M; Lenert P; Suneja M
Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
[TBL] [Abstract][Full Text] [Related]
16. Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.
Keasberry J; Frazier J; Isbel NM; Van Eps CL; Oliver K; Mudge DW
J Med Case Rep; 2013 Jan; 7():20. PubMed ID: 23316942
[TBL] [Abstract][Full Text] [Related]
17. Overlapping systemic lupus erythematosus, seropositive erosive rheumatoid arthritis, and ANCA-associated vasculitis: A case report and literature review.
Reesor E; Bhavsar SV
Mod Rheumatol Case Rep; 2023 Dec; 8(1):21-25. PubMed ID: 37804186
[TBL] [Abstract][Full Text] [Related]
18. Hydralazine associated pauci-immune glomerulonephritis.
Suneja M; Baiswar S; Vogelgesang SA
J Clin Rheumatol; 2014 Mar; 20(2):99-102. PubMed ID: 24561415
[TBL] [Abstract][Full Text] [Related]
19. Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.
Morimoto K; Kanzaki G; Niikura T; Koike K; Matsuo N; Maruyama Y; Tsuboi N; Yokoo T
BMC Nephrol; 2021 Aug; 22(1):294. PubMed ID: 34461843
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis.
Acharya I; Weisman DS; Smith LW; Arend LJ
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
